RajKBatraMD

PubMed

• 3 citations
  Non-invasive early detection of malignant pulmonary nodules by FISH-based sputum test.
  Dekel Shlomi, Nir Peled, Yehuda Schwarz, Guy W. Soo Hoo, Raj K. Batra, Gershon Fink, Tal Kaplan, Lahav Cohen, Scott Mollan, William R. Burfeind> ;Cancer Genetics. 2018 Oct 1
• 25 citations
  p16 Protein and gigaxonin are associated with the ubiquitination of NFκB in cisplatin-induced senescence of cancer cells
  Mysore S. Veena, Reason Wilken, Junying Zheng, Ankur A. Gholkar, Natarajan Venkatesan, Darshni Vira, Sameer Ahmed, Saroj K. Basak, Clifton L. Dalgard, Sandhiya Ravicha...> ;The Journal of Biological Chemistry. 2014 Dec 12
• 8 citations
  The CD44(high) tumorigenic subsets in lung cancer biospecimens are enriched for low miR-34a expression.
  Saroj K Basak, Mysore S Veena, Scott Oh, Chi Lai, Sitaram Vangala, David Elashoff, Michael C Fishbein, Sanjai Sharma, Nagesh P Rao, Dinesh Rao, Ryan Phan, Eri S Srivat...> ;Plos One. 2013 Jan 1
• 2 citations
  Correction: The CD44Tumorigenic Subsets in Lung Cancer Biospecimens Are Enriched for Low miR-34a Expression.
  Saroj K Basak, Mysore S Veena, Scott Oh, Chi Lai, Sitaram Vangala, David Elashoff, Michael C Fishbein, Sanjai Sharma, Nagesh P Rao, Dinesh Rao, Ryan Phan, Eri S Srivat...> ;Plos One. 2013 Jan 1
• 39 citations
  Cancer stem cells, microRNAs, and therapeutic strategies including natural products
  Darshni Vira, Saroj K. Basak, Mysore S. Veena, Marilene B. Wang, Raj K. Batra, Eri S. Srivatsan> ;Cancer Metastasis Reviews. 2012 Jul 1
• 12 citations
  Sprouty keeps bowel kinases regular in colon cancer, while miR-21 targets Sprouty.
  Mark R. Frey, Gianni Carraro, Raj K. Batra, D. Brent Polk, David Warburton> ;Cancer Biology & Therapy. 2011 Jan 1
• 3 citations
  On the derivation and clinical implications of "driver" mutations in lung cancer.
  Raj K. Batra, David Warburton> ;American Journal of Respiratory and Critical Care Medicine. 2010 Jul 1
• 24 citations
  Regression of Recurrent Respiratory Papillomatosis With Celecoxib and Erlotinib Combination Therapy
  Atikun Limsukon, Irawan Susanto, Guy W. Soo Hoo, Steven M. Dubinett, Raj K. Batra> ;Chest. 2009 Sep 1
• 49 citations
  The Malignant Pleural Effusion as a Model to Investigate Intratumoral Heterogeneity in Lung Cancer
  Saroj K. Basak, Mysore S. Veena, Scott Oh, Ge Huang, Eri Srivatsan, Min Huang, Sherven Sharma, Raj K. Batra> ;Plos One. 2009 Jun 12
• 15 citations
  CAR mediates efficient tumor engraftment of mesenchymal type lung cancer cells.
  Mysore S. Veena, Min Qin, Åsa Andersson, Sherven Sharma, Raj K. Batra> ;Laboratory Investigation; a Journal of Technical Methods and Pathology. 2009 Jun 8
• 82 citations
  IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancer.
  Åsa Andersson, Seok-Chul Yang, Min Huang, Li Zhu, Upendra K. Kar, Raj K. Batra, David Elashoff, Robert M. Strieter, Steven M. Dubinett, Sherven Sharma> ;Journal of Immunology. 2009 Jun 1
• 33 citations
  Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer.
  Felicita Baratelli, Hiroko Takedatsu, Saswati Hazra, Katherine A. Peebles, Jie Luo, Pam S Kurimoto, Gang Zeng, Raj K. Batra, Sherven Sharma, Steven M. Dubinett, Jay M....> ;Journal of Translational Medicine. 2008 Jul 22
• 71 citations
  Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase.
  Saswati Hazra, Raj K. Batra, Hsin H. Tai, Sherven Sharma, Xiaoyan Cui, Steven M. Dubinett> ;Molecular Pharmacology. 2007 Jun 1
• 224 citations
  Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer
  Mariam Dohadwala, Seok-Chul Yang, Jie Luo, Sherven Sharma, Raj K. Batra, Min Huang, Ying Lin, Lee Goodglick, Kostyantyn Krysan, Michael C. Fishbein, Longsheng Hong, Ch...> ;Cancer Research. 2006 May 15
• 38 citations
  CCL19 reduces tumour burden in a model of advanced lung cancer
  Sven Hillinger, Seok-Chul Yang, Raj K. Batra, Robert M. Strieter, Walter Weder, Steven M. Dubinett, Sanjai Sharma> ;British Journal of Cancer. 2006 Apr 10
• 66 citations
  Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma
  Seok-Chul Yang, Raj K. Batra, Sven Hillinger, Karen L. Reckamp, Robert M. Strieter, Steven M. Dubinett, Sherven Sharma> ;Cancer Research. 2006 Mar 15
• 1 citations
  New gene and cell-based therapies for lung cancer.
  Raj K. Batra, Sherven Sharma, Steven M. Dubinett> ;Seminars in Respiratory and Critical Care Medicine. 2000 Jan 1
• 57 citations
  Cyclooxygenase 2 Inhibition Promotes IFN-γ-Dependent Enhancement of Antitumor Responses
  Sherven Sharma, Li Zhu, Seok Chul Yang, Ling Zhang, Jeff F. Lin, Sven Hillinger, Brian Gardner, Karen L. Reckamp, Robert M. Strieter, Min Huang, Raj K. Batra, Steven M...> ;Journal of Immunology. 2005 Jul 15
• 381 citations
  Tumor Cyclooxygenase-2/Prostaglandin E2–Dependent Promotion of FOXP3 Expression and CD4+CD25+ T Regulatory Cell Activities in Lung Cancer
  Sherven Sharma, Seok-Chul Yang, Li Zhu, Karen L. Reckamp, Brian Gardner, Felicita Baratelli, Min Huang, Raj K. Batra, Steven M. Dubinett> ;Cancer Research. 2005 Jun 15
• 9 citations
  Gene Transfer Mediated by Native versus Fibroblast Growth Factor–Retargeted Adenoviral Vectors into Lung Cancer Cells
  Min Qin, Brian Escuadro, Sherven Sharma, Raj K. Batra> ;American Journal of Respiratory Cell and Molecular Biology. 2005 Mar 1
• 24 citations
  A novel role for the coxsackie adenovirus receptor in mediating tumor formation by lung cancer cells.
  Min Qin, Brian Escuadro, Mariam Dohadwala, Sherven Sharma, Raj K. Batra> ;Cancer Research. 2004 Sep 15
• 113 citations
  Intratumoral Administration of Dendritic Cells Overexpressing CCL21 Generates Systemic Antitumor Responses and Confers Tumor Immunity
  Seok Chul Yang, Sven Hillinger, Karen Riedl, Ling Zhang, Li Zhu, Min Huang, Kimberly Calica Atianzar, Brian Y. Kuo, Brian Gardner, Raj K. Batra, Robert M. Strieter, St...> ;Clinical Cancer Research. 2004 Apr 15
• 104 citations
  Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer.
  Mehis Põld, Li X. Zhu, Sherven Sharma, Marie D. Burdick, Ying Lin, Peter P N Lee, Anu Põld, Jie Luo, Kostyantyn Krysan, Mariam Dohadwala, Jenny T. Mao, Raj K. Batra, R...> ;Cancer Research. 2004 Mar 1
• 63 citations
  EBV-Induced Molecule 1 Ligand Chemokine (ELC/CCL19) Promotes IFN-γ-Dependent Antitumor Responses in a Lung Cancer Model
  Sven Hillinger, Seok Chul Yang, Li Zhu, Min Huang, Russell Duckett, Kimberly Calica Atianzar, Raj K. Batra, Robert M. Strieter, Steven M. Dubinett, Sherven Sharma> ;Journal of Immunology. 2003 Dec 15
• 26 citations
  Overexpression of CCL-21/secondary lymphoid tissue chemokine in human dendritic cells augments chemotactic activities for lymphocytes and antigen presenting cells.
  Karen Riedl, Felicita Baratelli, Raj K. Batra, Seok Chul Yang, Jie Luo, Brian Escuadro, Robert A. Figlin, Robert M. Strieter, Sherven Sharma, Steven M. Dubinett> ;Molecular Cancer. 2003 Nov 2
• Join now to see all

Journal Articles

• The CD44(high) Tumorigenic Subsets in Lung Cancer Biospecimens Are Enriched for Low miR-34a Expression  
  Basak SK, Veena MS, Oh S, Lai C, Vangala S, Elashoff D, Fishbein MC, Sharma S, Rao NP, Rao D, Phan R, Srivatsan ES, Batra RK, PLoS ONE, 9/3/2013
• The CD44high tumorigenic subsets in lung cancer biospecimens are enriched for low miR-34a expression.  
  Basak SK, MS Veena, S Oh, C Lai, S Vangala, D Elashoff , MC Fishbein, S Sharma, NP Rao, D Rao, R Phan, ES Srivatsan, and RK Batra, PLoS ONE, 9/3/2013
• The CD44 tumorigenic subsets in lung cancer biospecimens are enriched for low miR-34a expression  
  Basak SK, MS Veena, S Oh, C Lai, S Vangala, Dhighlashoff , MC Fishbein, S Sharma, NP Rao, D Rao, ER Phan, ES Srivatsan, and RK Batra, PLoS One, 1/3/2013
• Reprogrammed cells for respiratory papillomatosis (Letter).  
  Batra RK, Soo Hoo GW, N Engl J Med, 12/27/2012
• Cancer stem cells, microRNAs, and therapeutic strategies, including natural products.  
  Darshni Vira, SK. Basak, MS. Veena, MB. Wang, RK. Batra* , and ES Srivatsan,* (*Co-corresponding author), Cancer and Metastases Reviews, 12/1/2012
• Reprogrammed cells for respiratory papillomatosis  
  Batra RK, Soo Hoo GW, N Engl J Med, 1/27/2012
• Sprouty keeps bowel kinases regular in colon cancer, while miR-21 targets Sprouty.  
  Frey MR, Carraro G, Batra RK, Polk DB, Warburton D, Cancer Biol Ther, 1/1/2011
• On the derivation and clinical implications of "driver" mutations in lung cancer.  
  Batra RK and D Warburton, Am J Resp. and Critical Care Med., 7/1/2010
• Regression of recurrent respiratory papillomatosis with celecoxib and erlotinib combination therapy.  
  Limsukon A, I Susanto, G Soo Hoo, SM Dubinett, and RK Batra, Chest, 9/1/2009
• CAR mediates efficient tumor engraftment of mesenchymal type lung cancer cells.  
  Veena MS, M Qin, A Andersson, S Sharma, and RK Batra, Lab Invest, 8/1/2009
• The malignant pleural effusion as a model to investigate intratumoral heterogeneity in lung cancer.  
  Basak SK, MS Veena, S Oh, G Huang, E Srivatsan, M Huang, S Sharma, and RK Batra, PLoS ONE, 6/12/2009
• IL-7 Promotes CXCR3 Ligand-Dependent T Cell Antitumor Reactivity in Lung Cancer.  
  Andersson A, SC Yang, M Huang, L Zhu, UK Kar, RK Batra, D Elashoff, RM Strieter, SM Dubinett, and S Sharma, J Immunol, 6/1/2009
• Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non- Small Cell Lung Cancer.  
  Baratelli F, H Takedatsu, S Hazra, K Peebles, J Luo, PS Kurimoto, G Zeng, RK Batra, S Sharma, SM Dubinett, JM Lee, J Translational Med, 7/22/2008
• Pioglitazone and Rosiglitazone decrease PGE2 in non-small cell lung cancer cells by upregulating 15-hydroxyprostaglandin dehydrogenase.  
  Hazra S, RK Batra, HH Tai, S Sharma S, X Cui, SM Dubinett, Mol Pharmacol, 6/1/2007
• Cyclooxygenase-2-Dependent Regulation of E-Cadherin: Prostaglandin E2 Induces Transcriptional Repressors ZEB1 and Snail in Non-Small Cell Lung Cancer.  
  Dohadwala M, SC Yang, J Luo, S Sharma, RK Batra, M Huang, Y Lin, L Goodglick, K Krysan, MC Fishbein, L Hong, C Lai, RB Cameron, RM Gemmill, HA Drabkin, SM Dubinett, Cancer Research, 5/15/2006
• CCL19 reduces tumor burden in a model of advanced lung cancer.  
  Hillinger S, SC Yang, RK Batra, RM Strieter, W Weder, SM Dubinett, S Sharma, Br J Cancer, 4/10/2006
• Intrapulmonary Administration of CCL21 Gene-Modified Dendritic Cells Reduces Tumor Burden in Spontaneous Murine Bronchoalveolar Cell Carcinoma.  
  Yang SC, RK Batra, S Hillinger, KL Reckamp, RM. Strieter, SM, Dubinett, and S Sharma, Cancer Research, 1/1/2006
• Cyclooxygenase 2 Inhibition Promotes IFN-{gamma}-Dependent Enhancement of Antitumor Responses.  
  Sharma S, L Zhu, SC Yang, L Zhang, J Lin, S Hillinger, B Gardner, K Reckamp, RM. Strieter, M Huang, RK Batra, SM Dubinett, J Immunol, 7/15/2005
• Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.  
  Sharma S, SC Yang, L Zhu, K Reckamp, B Gardner, F Baratelli, M Huang, RK Batra, SM Dubinett, Cancer Research, 6/15/2005
• Gene transfer mediated by native versus FGF2-retargeted adenoviral vectors into lung cancer cells.  
  Qin M, B Escuadro, S Sharma, and RK Batra, Am J Respir Cell Mol Biol, 3/1/2005
• A novel role for the Coxsackie-Adenovirus Receptor in mediating tumor formation by lung cancer cells.  
  Qin M, B Escuadro, M Dohadwala, S. Sharma, and RK Batra, Cancer Research, 9/15/2004
• Intramural administration of dendritic cells over-expressing CCL21 generates systemic antitumor responses and immunity: the importance of IFNg, MIG/CXCL9 and IP-10/CXC...  
  Yang SC, S Hillinger, K Riedl, L Zhang, L Zhu, M Huang, K Atianzar, BY Kuo, B Gardner, RK Batra, RM Strieter, SM Dubinett, S Sharma, Clinical Cancer Res, 4/15/2004
• Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer.  
  Pold M, LX Zhu, S Sharma, MD Burdick, Y Lin, PP Lee, A Pold, J Luo, K Krysan, M Dohadwala, JT Mao, RK Batra, RM Strieter, SM Dubinett, Cancer Research, 3/1/2004
• Intratumoral administration of dendritic cells over- expressing CCL21 generates systemic antitumor responses and immunity: the importance of IFNg, MIG/CXCL9 and IP-10/...  
  Yang SC, S Hillinger, K Riedl, L Zhang, L Zhu, M Huang, K Atianzar, BY Kuo, B Gardner, RK Batra, RM Strieter, SM Dubinett, S Sharma, Clinical Cancer Res, 1/15/2004
• EBV-Induced molecule 1 ligand chemokine (ELC/CCL19) promotes IFN-gamma-dependent antitumor responses in a lung cancer model.  
  Hillinger S, SC Yang, L Zhu, M Huang, R Duckett, K Atianzar, RK Batra, RM Strieter, SM Dubinett, S Sharma, J Immunol, 12/15/2003
• Join now to see all

Books/Book Chapters

• Stem Cells, Tissue Engineering and Regenerative Medicine 
  Chapter: The isolation and molecular characterization of cancer stem cells (aggressive endophenotypes) in individual lung cancers 
  Batra RK, S. Oh and SK BasakEditors: David Warburton.Imperial College Press, London, England2014
• Methods in Molecular Medicine Series, "Lung Cancer". 
  Chapter: Cyclooxygenase-2-Dependent Regulation of Antitumor Immunity in Lung Cancer. 
  Page 723 - 738S Sharma, M Huang, M Dohadwala, M Pold, RK Batra, and SM DubinettEditors: Barbara Driscoll.Humana Press, USA2003
• Methods in Molecular Medicine Series, "Lung Cancer". 
  Chapter: Intratumoral Therapy with Cytokine Gene-Modified Dendritic Cells in Muring Lung Cancel Models. 
  Page 711 - 722S Sharma, SC Yang, RK Batra, and SM DubinettEditors: Barbara Driscoll.Humana Press, USA2003
• Methods in Molecular Medicine Series, "Lung Cancer". 
  Chapter: Obstacles to Efficacious Viral gene transfer in vivo; Malignant Pleural Effusions as a Paradigm. 
  Page 545 - 560Batra RK, S. Sharma and R BernalEditors: Barbara Driscoll.Humana Press, USA2003
• Methods in Molecular Medicine Series, "Lung Cancer" 
  Chapter: Cyclooxygenase-2-Dependent Regulation of Antitumor Immunity in Lung Cancer 
  Page 723 - 738S Sharma, M Huang, M Dohadwala, M Pold, RK Batra, and SM DubinettEditors: Barbara Driscoll.Humana Press2003
• Methods in Molecular Medicine Series, "Lung Cancer" 
  Chapter: Intratumoral Therapy with Cytokine Gene-Modified Dendritic Cells in Muring Lung Cancer Models 
  Page 711 - 722S Sharma, SC Yang, RK Batra, and SM DubinettEditors: Barbara Driscoll.Humana Press2003
• Methods in Molecular Medicine Series, "Lung Cancer" 
  Chapter: Obstacles to Efficacious Viral gene transfer in vivo; Malignant Pleural Effusions as a Paradigm 
  Page 545 - 560Batra RK, S. Sharma and R Bernal2003
• Adenoviral Vectors for Gene Therapy. 
  Chapter: Utility of Adenoviral Vectors in animal models of human disease I: Cancer. 
  Batra RK, S. Sharma and Lily WuEditors: DT Curiel and JT Douglas.Academic Press, USA2002
• Lung Biology in Health and Disease Series, "Gene Therapy in Lung Disease". 
  Chapter: Gene Therapy for Lung Cancer. 
  Batra RK, Sherven Sharma, Robert M Strieter, and Steven M. DubinettEditors: Steven M. Albelda and Claude Lenfant.Marcel Dekker, New York, NY2002
• Adenoviral Vectors for Gene Therapy 
  Chapter: Utility of Adenoviral Vectors in animal models of human disease I: Cancer 
  Batra RK, S. Sharma and Lily WuEditors: DT Curiel and JT Douglas.Academic Press2002
• Lung Biology in Health and Disease Series, "Gene Therapy in Lung Disease" 
  Chapter: Gene Therapy for Lung Cancer 
  Batra RK, Sherven Sharma, Robert M Strieter, and Steven M. DubinettEditors: Steven M. Albelda and Claude Lenfant.Marcel Dekker, New York, NY2002
• Join now to see all

Abstracts/Posters

• "Intratumoral heterogeneity and the cancer stem cell phenotype in lung cancer".
  Batra RK, UCLA/GLAVAHS Pancreatic Research Group, Los Angeles, CA, 9/1/2009
• "Development of the malignant pleural effusion model to investigate intratumoral heterogeneity in lung cancer".
  Batra RK, 104th International Conference of the ATS, San Diego, CA, 5/1/2009
• "CAR-expression is essential for tumor formation by lung cancer xenografts".
  Batra RK, Mini-symposium, 2004 ASGT International Conference, Minneapolis, MN, 6/1/2004
• "CAR-expression is essential for tumor formation by lung cancer xenografts".
  Batra RK, Poster Discussion-2004 ATS International Conference, Orlando, FL, 5/1/2004
• "Lung Cancer: Molecular and Cellular Biology".
  Batra RK, 2004 ATS International Conference Poster-Discussion Session, Facilitator, Orlando, FL, 5/1/2004
• "CAR-expression is essential for tumor formation by lung cancer xenografts".
  Batra RK, Poster Discussion-2004 AACR International Conference, Orlando, FL, 3/1/2004
• CAR-expression is essential for tumor formation by lung cancer xenografts
  Batra RK, AACR International Conference, Orlando, FL, 1/1/2004
• CAR-expression is essential for tumor formation by lung cancer xenografts
  Batra RK, ATS International Conference, Orlando, FL, 1/1/2004
• Lung Cancer: Molecular and Cellular Biology
  Batra RK, ATS International Conference, Orlando, FL, 1/1/2004
• "Gene Therapy".
  Batra RK, ATS International Conference, Thematic Poster Session, Facilitator, Seattle, WA, 5/1/2003
• "Soluble CAR is an inhibitor of adenoviral gene transfer in malignant pleural effusions."
  Batra RK, American Society of Gene Therapy Annual Conference, Seattle, WA, 6/1/2001
• "Uncovering Obstacles to in vivo gene therapy for lung cancer: Malignant pleural effusions as a paradigm."
  Batra RK, Career Development Awardee Research Seminar, Veterans Administration Medical Research Advisory Group Annual Conference, Albuquerque, NM, 3/1/2001
• "In Vivo Barriers to Gene Transfer by Viral Vectors".
  Batra RK, UCLA Department of Human Genetics and The UCLA Gene Medicine Program Symposia, Los Angeles, CA, 5/1/1999
• "Iota Kappa Beta Alpha-Gene Transfer into Lung Cancer Cells Induces Cytotoxicity and Apoptosis".
  Batra RK, American Thoracic Society International Conference, Poster/Discussion, San Diego, CA, 4/1/1999
• "Iota Kappa Beta Alpha-Gene Transfer into Lung Cancer Cells Induces Cytotoxicity and Apoptosis".
  Batra RK, ALA-Southern California Pulmonary and Critical Care Medicine Research Conference, Palm Springs, CA, 2/1/1999
• I kappa B alpha-Gene Transfer into Lung Cancer Cells Induces Cytotoxicity and Apoptosis
  Batra RK, American Thoracic Society International Conference, San Diego, CA, 1/1/1999
• "Iota Kappa Beta Alpha-Gene Transfer as a Therapeutic for NSCLC".
  Batra RK, UCLA Third Annual Human Gene Medicine Symposium, Los Angeles, CA, 6/1/1998
• "Inhibition of Retroviral Gene Transfer by Chondroitin Sulfates in Malignant Effusions".
  Batra RK, UCLA-Jonsson Comprehensive Cancer Center, Los Angeles, CA, 10/1/1997
• "Inhibition of Retroviral Gene Transfer by Chondroitin Sulfates in Malignant Effusions".
  Batra RK, John Wayne Cancer Institute, Santa Monica, CA, 10/1/1997
• "Gene Therapy of Lung Cancer".
  Batra RK, North Carolina Chapter of the American Association of Physicians of Indian Descent, Raleigh, NC, 8/1/1996
• Join now to see all

Lectures

• Approaches to jointly validate biomarkers and identify targets for cancer 
  San Diego, CA - 1/18/2015
• A novel vertically integrated phenotype-based approach to validate biomarkers and identify molecular targets in cancer 
  Harbor-UCLA Medical Center, Torrance, CA - 1/14/2014
• "An Approach to Discover Novel Targets and Rational Combinatorial Approaches to Treat Cancer." 
  San Diego, CA - 3/22/2013
• "The MPE-model to study disease evolution in lung cancer." 
  1100 Terasaki Life Sciences Bldg., UCLA, Los Angeles, CA - 3/13/2013
• An Approach to Discover Novel Targets and Rational Combinatorial Approaches to Treat Cancer 
  Cambridge Healthtech Institute, San Diego, CA - 1/22/2013
• The MPE-model to study disease evolution in lung cancer 
  UCLA, Los Angeles, CA - 1/13/2013
• A novel phenotype-based approach to validate biomarkers and identify molecular targets in cancer 
  University of California, San Diego, San Diego, CA - 1/1/2013
• "An approach to derive the molecular signatures of aggressive lung cancer." 
  Harbor UCLA, Torrance, CA - 4/10/2012
• "A translational approach to derive the molecular signatures of aggressive lung cancer." 
  Denver, CO - 4/3/2012
• An approach to derive the molecular signathtures of aggressive lung cancer 
  Harbor UCLA, Torrence, CA - 1/10/2012
• A translational approach to derive the molecular signatures of aggressive lung cancer 
  University of Colorado Comprehensive Cancer Center and the UC-SPORE in Lung Cancer, VA-Denver, and t - 1/3/2012
• "A novel phenotype-based approach to the study of lung cancer." 
  San Diego, CA - 10/1/2011
• "A phenotype-based approach to the study of lung cancer." 
  Los Angeles, CA - 2/1/2011
• An introduction to the concept of endophenotypes for the study of lung cancer 
  Los Angeles, CA - 1/1/2011
• A novel phenotype-based approach to the study of lung cancer 
  University of California, San Diego, San Diego, CA - 1/1/2011
• "An introduction to the concept of endophenotypes for the study of lung cancer." 
  Los Angeles, CA - 1/1/2011
• "A phenotype-based approach to the study of lung cancer". 
  Los Angeles, CA - 11/1/2010
• A phenotype-based approach to the study of lung cancer 
  Los Angeles, CA - 1/1/2010
• Facilitator, ATS-Session Title: Lung Cancer Mechanisms of Initiation and Progression. 
  San Diego, CA - 5/1/2009
• Development of theth malignant pleural effusion model to investigate intratumoral heterogeneity in lung cancer 
  San Diego, CA - 1/1/2009
• Intratumoral heterogeneity and the cancer stem cell phenotype in lung cancer 
  Los Angeles, CA - 1/1/2009
• "Lung Cancer: From Cell to Cure". 
  San Francisco, CA - 5/1/2007
• Lung Cancer: From Cell to Cure 
  San Francisco, CA - 1/1/2007
• "Developing Gene Therapy for Lung Cancer: CAR as a transduction-target". 
  UCLA, Los Angeles, CA - 11/1/2006
• "Lung Cancer Facts: Causes, Treatment and Trends in Research". 
  Los Angeles, CA - 10/1/2006
• Join now to see all

Other

• Decoding Autism: An interview with Genome Magazine regarding the prospects of Precision Medicine for Autism 
  Batra RK
  http://genomemag.com/decoding-autism/#.VZQXMe1VhBc
  1/1/2015